Galderma’s Restylane Shaype Approved in Mexico for Chin and Jawline Enhancement
Galderma Aesthetics announced that Restylane Shaype is now approved in Mexico for temporary augmentation in the chin area and improvement of jawline definition. The approval marks the product’s first jawline indication worldwide.
Restylane Shaype is a hyaluronic acid (HA) filler, developed to deliver a unique bone-mimicking effect and enable natural-looking structural enhancement without surgery.
According to Galderma, the approval was supported by clinical data evaluating aesthetic improvement in the chin and jawline areas. The company said the product is designed to provide support and projection while maintaining a natural appearance and facial movement.
Restylane Shaype is not currently approved for use in the United States.
